Related Experiment Video
Updated: Feb 10, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Optimizing therapy in bortezomib-exposed patients with multiple myeloma
Magdalini Migkou1, Maria Gavriatopoulou1, Evangelos Terpos1
1a Oncology Department, Department of Clinical Therapeutics , Alexandra Hospital, National and Kapodistrian University of Athens , Athens , Greece.
Introduction:
Multiple myeloma prognosis has improved significantly during the past decade, with survival prolongation mainly due to the incorporation of novel agents. Bortezomib represents one of the main backbone agents of antimyeloma treatment. Areas covered: This review aims to identify possible and available therapeutic options for patients who experience disease refractoriness following bortezomib exposure. Expert commentary: For patients who finally relapse after bortezomib exposure treatment strategy should be individualized. For patients with disease resistant to bortezomib, the combination of lenalidomide-dexamethasone with a monoclonal antibody seems to be the most optimal choice for second-line treatment. For third line, pomalidomide-based regimens can be effective even in bortezomib refractory patients. Several novel agents are currently under investigation in order to treat multi-refractory disease.G.
Related Concept Videos
Gene Therapy
Optimal Foraging
Multiple Allele Traits
Optimization Problems
Group Therapy
Multiple Regression
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...

